- Business Model
- B2B
- Website
- likarda.com
- Total Funding
- $4.0M
- Last Round
- $4.0M Series AAug 2017
- Rounds
- 1
About
Likarda is a biotech company founded by science entrepreneur Lisa Stehno-Bittel, PhD, following her research career at the University of Kansas Medical Center, where she developed a pioneering 3D cell culture platform. The company's encapsulation platform protects cells and molecules from immune attack and harsh environments, controls release from hours to months to match therapeutic need, and has been proven across 40+ cell types, including applications in immune-evasive cell therapies for diabetes and cartilage regeneration for osteoarthritis.
Summary
Likarda is a Biotech company. It has raised $4.0M in total across 1 round, most recently a $4.0M Series A round in Aug 2017. Investors include Werth Family Investment Associates.
Funding History
Aug 2017
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/likarda"><img src="https://indexed.vc/api/badge/company/likarda" alt="Likarda on Indexed.vc" width="260" height="76" /></a>